| Line Item | 2025-09-30 | Q/Q | Y/Y |
|---|---|---|---|
| Revenue | $3.1M | +13.9% | +23.5% |
| Cost of Revenue | $4.7M | +28.2% | +45.3% |
| Gross Profit | -$1.6M | -71.0% | -124.3% |
| R&D Expense | $3.8M | +79.8% | +113.2% |
| SG&A Expense | $3.1M | -5.4% | -27.4% |
| Operating Income | -$9.5M | -51.7% | -22.8% |
| Pre-tax Income | -$9.5M |
| Line Item | 2025-09-30 | Q/Q | Y/Y |
|---|---|---|---|
| Cash & Equivalents | $20.4M | +148.3% | +292.2% |
| Accounts Receivable | $2.5M | -1.1% | +4.6% |
| Inventory | $1.8M | +4.4% | -37.2% |
| Current Assets | $25.8M | +94.2% | +123.9% |
| Total Assets | $41.1M | +40.5% | +64.8% |
| Current Liabilities |
| Line Item | 2025-09-30 | Q/Q | Y/Y |
|---|---|---|---|
| Operating Cash Flow | -$19.7M | — | — |
| Capital Expenditures | $412K | — | — |
| Investing Cash Flow | -$1.9M | — | — |
| Financing Cash Flow | $30.8M | — | — |
| Free Cash Flow | -$20.1M | — | — |
| -50.7% |
| +12.5% |
| Net Income | -$9.5M | -50.7% | +12.5% |
| EPS (Basic) | -$0.98 | -8.9% | +72.6% |
| EPS (Diluted) | -$0.98 | -8.9% | +72.6% |
| $7.1M |
| +1.7% |
| -38.1% |
| Long-term Debt | $4.0M | +0.1% | +1.6% |
| Total Liabilities | $14.2M | +0.4% | -9.6% |
| Stockholders' Equity | $26.9M | +77.9% | +190.6% |